Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharyngeal Neoplasms | 2 | 2013 | 6 | 0.720 |
Why?
|
| Mouth Neoplasms | 2 | 2013 | 60 | 0.690 |
Why?
|
| DNA Repair | 2 | 2017 | 198 | 0.560 |
Why?
|
| Anus Neoplasms | 1 | 2014 | 44 | 0.410 |
Why?
|
| Papillomavirus Infections | 4 | 2024 | 376 | 0.400 |
Why?
|
| Puerto Rico | 9 | 2018 | 1413 | 0.360 |
Why?
|
| Registries | 1 | 2013 | 437 | 0.350 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 15 | 0.300 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 310 | 0.280 |
Why?
|
| Biomedical Research | 1 | 2012 | 502 | 0.250 |
Why?
|
| Alphapapillomavirus | 2 | 2018 | 31 | 0.240 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 704 | 0.230 |
Why?
|
| Incidence | 3 | 2014 | 1078 | 0.230 |
Why?
|
| Prediabetic State | 2 | 2016 | 69 | 0.230 |
Why?
|
| Aged | 8 | 2024 | 8214 | 0.230 |
Why?
|
| Risk Factors | 6 | 2017 | 3994 | 0.220 |
Why?
|
| Plasma Cells | 1 | 2024 | 12 | 0.210 |
Why?
|
| Intention | 1 | 2024 | 108 | 0.200 |
Why?
|
| Heart Transplantation | 1 | 2024 | 47 | 0.200 |
Why?
|
| Vaccination | 1 | 2024 | 355 | 0.180 |
Why?
|
| Papillomavirus Vaccines | 1 | 2024 | 174 | 0.180 |
Why?
|
| Middle Aged | 9 | 2024 | 12222 | 0.170 |
Why?
|
| Parents | 1 | 2024 | 370 | 0.170 |
Why?
|
| Survival Rate | 2 | 2014 | 355 | 0.170 |
Why?
|
| Neoplasms | 1 | 2012 | 1377 | 0.170 |
Why?
|
| Humans | 16 | 2024 | 43102 | 0.170 |
Why?
|
| Glucose Tolerance Test | 2 | 2019 | 75 | 0.160 |
Why?
|
| Life Style | 2 | 2019 | 334 | 0.160 |
Why?
|
| Female | 10 | 2024 | 24698 | 0.150 |
Why?
|
| Metformin | 1 | 2019 | 75 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2017 | 490 | 0.140 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 184 | 0.140 |
Why?
|
| Male | 7 | 2024 | 23409 | 0.130 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2018 | 95 | 0.130 |
Why?
|
| Adult | 9 | 2024 | 13872 | 0.130 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1285 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 1067 | 0.120 |
Why?
|
| Genomics | 1 | 2018 | 293 | 0.120 |
Why?
|
| Culture | 1 | 2016 | 172 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2018 | 306 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 760 | 0.110 |
Why?
|
| Palatal Neoplasms | 1 | 2013 | 2 | 0.100 |
Why?
|
| Tonsillar Neoplasms | 1 | 2013 | 2 | 0.100 |
Why?
|
| Tongue Neoplasms | 1 | 2013 | 9 | 0.100 |
Why?
|
| SEER Program | 1 | 2013 | 164 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 374 | 0.100 |
Why?
|
| Self Administration | 1 | 2013 | 69 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 186 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2013 | 63 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2013 | 81 | 0.090 |
Why?
|
| Papillomaviridae | 1 | 2013 | 142 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 291 | 0.090 |
Why?
|
| Prognosis | 1 | 2014 | 861 | 0.090 |
Why?
|
| Age Factors | 2 | 2016 | 1154 | 0.080 |
Why?
|
| United States | 2 | 2013 | 5205 | 0.080 |
Why?
|
| DNA Damage | 1 | 2012 | 356 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 539 | 0.080 |
Why?
|
| Schools, Medical | 1 | 2012 | 208 | 0.080 |
Why?
|
| Time Factors | 1 | 2014 | 1857 | 0.080 |
Why?
|
| Thyrotropin | 1 | 2008 | 24 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 174 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2008 | 43 | 0.070 |
Why?
|
| Menopause | 1 | 2008 | 64 | 0.070 |
Why?
|
| Software | 1 | 2009 | 236 | 0.070 |
Why?
|
| Sex Factors | 2 | 2024 | 1028 | 0.070 |
Why?
|
| Algorithms | 1 | 2009 | 509 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2019 | 389 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 2853 | 0.060 |
Why?
|
| Desensitization, Immunologic | 1 | 2024 | 2 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 3156 | 0.050 |
Why?
|
| Isoantibodies | 1 | 2024 | 9 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2024 | 27 | 0.050 |
Why?
|
| Young Adult | 4 | 2018 | 5080 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2024 | 43 | 0.050 |
Why?
|
| Adolescent | 3 | 2024 | 6081 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1723 | 0.040 |
Why?
|
| Prevalence | 2 | 2016 | 1612 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 497 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 28 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 40 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 173 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2019 | 317 | 0.040 |
Why?
|
| Models, Educational | 1 | 2018 | 46 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2018 | 74 | 0.030 |
Why?
|
| Problem-Based Learning | 1 | 2018 | 42 | 0.030 |
Why?
|
| Urban Health | 1 | 2018 | 101 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 989 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2016 | 25 | 0.030 |
Why?
|
| Physicians | 1 | 2018 | 188 | 0.030 |
Why?
|
| Students, Medical | 1 | 2018 | 158 | 0.030 |
Why?
|
| Curriculum | 1 | 2018 | 318 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 1604 | 0.030 |
Why?
|
| Uterine Cervical Diseases | 1 | 2013 | 14 | 0.020 |
Why?
|
| Anus Diseases | 1 | 2013 | 17 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 780 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 159 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 666 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 150 | 0.020 |
Why?
|
| Health Behavior | 1 | 2016 | 575 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 1234 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2013 | 311 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 611 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 800 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 835 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1009 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1081 | 0.020 |
Why?
|